Company intelligence / Profile preview

Oncolytics Biotech Inc.

Calgary, Alberta, Canadaoncolyticsbiotech.com ↗
Ownership
Public · ONCY
Employees
~40
Development stage
Other
01

Overview

Pelareorep has demonstrated promising efficacy and safety signals in multiple randomized Phase II trials for metastatic breast cancer and early-phase studies for pancreatic and anal cancers. The BRACELET‑1 trial in HR+/HER2− metastatic breast cancer showed substantial clinical benefit when pelareorep was combined with paclitaxel versus paclitaxel alone. GOBLET study cohorts have shown positive results in advanced pancreatic ductal adenocarcinoma, third-line colorectal cancer, and anal carcinoma. Both lead indications—metastatic breast and pancreatic cancers—have received FDA Fast Track designation

Therapeutic areas
Oncology
Modalities
ImmunotherapyViral-based immunotherapy (oncolytic virus)
Industry
Biotech
02

Drug pipeline

2 assets

pelareorep

3

1 more asset in the full pipeline.

03

Partnerships

Multiple academic collaborations(GOBLET study ,UniversityofCalgaryorigin )Pharmaceutical partnersforcombinationtrials(e.g .,AtezolizumabfromRoche )
04

Financials

Market cap
$45M
Total revenue
$0
Enterprise value
$41.4M

Beyond the preview

Go deeper on Oncolytics Biotech Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oncolytics Biotech Inc..

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call